For the Culture By The Culture
This week’s Reefer Report Card tracks rising tension across cannabis policy as the federal hemp derived THC crackdown threatens a multibillion dollar market, New York’s enforcement chaos drags on, and the Supreme Court prepares to weigh the future of prohibition. Veterans wait for real care, and global reform shows hesitation from Brazil to Germany and Thailand. Pressure is building everywhere.
This week’s Reefer Report Card tracks mounting pressure across the cannabis world as the federal hemp derived THC crackdown rattles a multibillion dollar market, New York’s enforcement chaos deepens, Germany’s legalization plan stalls, and global reform hits resistance. Veterans and patients remain stuck in outdated systems. A tense week for cannabis policy and international legalization.
This week’s Reefer Report Card exposes the hemp industry's battle for survival in the face of a proposed federal THC ban that threatens the entire hemp market. From state-level chaos to Congress playing politics with small farmers and patients, the hemp economy struggles to breathe. No real wins, just industry confusion and political games.
From Florida’s ballot grind to Thailand’s backpedal and Germany’s retreat, the world talked reform while tightening control. Pot Culture Magazine’s Reefer Report Card Vol. 22 grades the week in weed — a reality check on promises, policies, and politics that keep legalization crawling instead of sprinting. Global momentum stalled, but the culture keeps moving.
Michigan’s new 24 percent wholesale tax lit up outrage across the cannabis industry, while New York regulators faced a courtroom map lesson and Massachusetts tried to reboot its commission. Pennsylvania found compassion in hospital reform, and Germany slowed progress with new rules. Reefer Report Card Vol. 18 grades a week of taxes, lawsuits, and bureaucratic burnout.
A German biotech is pushing a cannabis pill called VER 01 and calling it a breakthrough for pain relief. Beneath the pharmaceutical polish is a deeper story about control, money, and culture. Pot Culture Magazine asks if Vertanical’s lab born weed is progress or just another corporate grab for the plant the people built.
